turn of the 20th century, Bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder cancer (NMIBC) has been in and out of favor. However, only a small proportion
Presentation: 64 years old female known diabetic evaluated for pain in right hypochondrium. Gall bladder cancer was suspected clinically as well on radiologically basis. Patient underwent extended cholecystectomy…
tested, compound 3, with two ethyl side chains, was found particularly bioactive in urinary bladder cancer cells, as it extinct the expression of oncogenic HRAS. We found that 3 stabilizes
were treated with different regimens of adjuvant chemotherapy after cholecystectomy due to Gall Bladder Cancer (GBC). Patients and Methods: Data of GBC Patients registered between January 2011 to January
analyze the main chemical constituents of Veratrum dahuricum, and study their antibladder cancer activity. Chloroform and ethyl acetate fractions are obtained by ethanol extraction, and subsequent extraction with…
Bladder cancer is a common cancer worldwide and its incidence continues to increase. There are approximately 261,000 cases of bladder cancer resulting in 115,000 deaths annually. This study ... aimed to integrate…
node dissection. The histopathology showed small neuroendocrine cells in the bladder and a prostate carcinoma (a low-risk cancer). At seven months post presentation, metastasis appeared at the bottom
Bladder cancer is a prevalent malignancy that affects the urinary bladder, and its epidemiology reveals a significant global impact. Based on data from the Surveillance, Epidemiology and End Results (SEER ... years 2016…
protein (FAP) from Bacillus Calmette-Guerin as a targeting agent for bladder tumor cells. International Journal of Cancer 131: 591-600. 4. Bode C, Zhao G, Steinhagen F, Kinjo
Bladder carcinoma is one of the commonest cancers in Australia and accounts for 2% of all cancers in Australia. According to the European Association of Urology (EAU) Guidelines, macroscopic Transurethral
promise in gall-bladder treatment is the inhibition of the master heat shock protein 90, which has emerged as an exciting target for cancer therapy, which is a master regulator
genetic mapping that permits interrogation of the chronology of genetic changes associated with cancer development on a whole-organ scale. By using this approach, we analyzed the sequence of genetic ... whose silencing…